chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cellulitis of left thigh - Give Keflex twice a day for 7 days, may use warm compress for a few minutes at a time. Watch for increase in size of swelling. swollen glands      swelling on left legs and area between groin and thigh since 15mo vaccines  This is a new problem.   Started after the pt received DtaP in left leg 8 days ago. The problem has been gradually worsening (some swelling since day of vaccines, but has enlarged for past 3 days, but not getting any larger since). Associated symptoms include swollen glands (in right groin (not left where swelling is)). Pertinent negatives include no fever or vomiting. Nothing aggravates the symptoms. He has tried nothing for the symptoms.  Swelling of thigh at site of vaccine, tender to touch but not red, no fever
On 4/16/21 I developed a kidney stone. I was treated and released home on medication.
Felt like she was going to pass out / dizziness; weakness; Itching in the back of her throat; Heavy cough; High temperature; Headache; Nausea; This spontaneous case was reported by a non-health professional and describes the occurrence of COUGH (Heavy cough), ASTHENIA (weakness), THROAT IRRITATION (Itching in the back of her throat), DIZZINESS (Felt like she was going to pass out / dizziness) and PYREXIA (High temperature) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Cholesterol. Concomitant products included ROSUVASTATIN for Cholesterol, AMLODIPINE and HCTZ for Hypertension, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Aug-2021, the patient experienced COUGH (Heavy cough), PYREXIA (High temperature), HEADACHE (Headache) and NAUSEA (Nausea). On 15-Aug-2021, the patient experienced ASTHENIA (weakness) and THROAT IRRITATION (Itching in the back of her throat). On 16-Aug-2021, the patient experienced DIZZINESS (Felt like she was going to pass out / dizziness). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. At the time of the report, COUGH (Heavy cough), ASTHENIA (weakness), THROAT IRRITATION (Itching in the back of her throat), DIZZINESS (Felt like she was going to pass out / dizziness), PYREXIA (High temperature), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Aug-2021, Blood pressure measurement: 147/102 (High) blood pressure was elevated to 147/102. On 14-Aug-2021, Heart rate: 105 (High) pulse rate was elevated to 105 as of the same evening. On 15-Aug-2021, Heart rate: 111 (High) pulse rate was elevated to 105/pulse rate was 111.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
PATIENT STATED HER FACE WAS SWOLLEN AND HER ARM WHERE PREVNAR WAS GIVEN WAS ALSO SWOLLEN.
Bilateral neck pain; Stiffness; Nauseous; Started dry heaving; Chills/ shivering; Sweating; Pressure headache; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 20Sep2021 11:30 (Lot number: FF2587) at the age of 26 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Herniated disc" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 20Sep2021 01:30, outcome "recovering", described as "Nauseous"; RETCHING (non-serious) with onset 20Sep2021 01:30, outcome "recovering", described as "Started dry heaving"; CHILLS (non-serious) with onset 20Sep2021 01:30, outcome "recovering", described as "Chills/ shivering"; HYPERHIDROSIS (non-serious) with onset 20Sep2021 01:30, outcome "recovering", described as "Sweating"; HEADACHE (non-serious) with onset 20Sep2021 01:30, outcome "not recovered", described as "Pressure headache"; NECK PAIN (non-serious) with onset 21Sep2021 01:30, outcome "not recovered", described as "Bilateral neck pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 21Sep2021, outcome "not recovered", described as "Stiffness". The events "nauseous", "started dry heaving", "chills/ shivering", "sweating", "pressure headache", "bilateral neck pain" and "stiffness" were evaluated at the physician office visit. Therapeutic measures were taken as a result of nausea, retching, chills, hyperhidrosis, headache, neck pain, musculoskeletal stiffness.  Additional information: After 2 hours of getting Pfizer vaccine she got nauseous and started dry heaving, chills, sweating, shivering, pressure headache. The second day her pressure headache intensified and bilateral neck pain began. The pressure headache has not gone away nor her neck pain/ stiffness. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The treatment received for the adverse event reported as Tylenol, ibuprofen. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.
Pt exp fussy all nite, t101, entire body started to jerk, eyes would not focus, pale, went limp for 1 min;
DIZZINESS; SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced sore arm. On 21-MAR-2021, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness on MAR-2021, and the outcome of sore arm was not reported. This report was non-serious.
pt recv vax 11SEP96 & 18NOV96 pt exp rash w/more than 50 lesions;
Tinnitus that developed in both ears, stuffy sensation in right ear, also mild stinging pain in back of throat that developed a few hours after dose
One week after the vaccine on 1/6/21 patient reported that her injection site was red, puffy, warm, and slightly itchy. She was evaluated at vaccine clinic by Dr. and he recommended a three day course with antihistamine and to report if no improvement.
pt recvd vax 13oct94; seen in er 14oct94; states had onset of wheezing 1 1/2 hrs after recvd vax;tx w/ EPI,DPH,Albuterol; 2 days later broke out in rash & swollen & wheezing; tx w/ O2 & meds;
Pt recv vax on 3/26/99; on 3/27/99 pt exp red/ swollen right thigh
Swollen cervical and axillary lymph nodes.  Pain. Extreme fatigue.
Symptoms began 2 days after second dose. Patient noticed a small lump on right breast, swollen lymph nodes, fever of 103, and redness on lower and inner side of breast. The lump grew in size to 5cm over the course of one week and redness spread to left side. Was prescribed Hydrocortisone and Bactrim for one week, and then Bactrim was D/C'd and was changed to Clindomycin and Hydrocortisone for 2 weeks. Was diagnosed with breast abscess and went to surgeon for incision and drainage. Wound was packed. Patient was instructed to continue antibiotics and to continue packing the wound. Wound has scabbed over and patient has completed antibiotics. Ultrasound has been scheduled for observation of lump.
Patient received Pfizer Covid Bivalent in error based on the information provided by the patient at the time of the vaccine.  Patient stated that he had received J&J as his primary series and was due for the bivalent. Website was down or pharmacy was having browser problems that evening.   Patient was very adament that he was due for a bivalent vaccine.   Error was caught when patient came back to the pharmacy insisting on another vaccine shot.   Based on this information, I reported this  error to VAERS  and am not giving the patient another vaccine until clarification from my supervisor.  Patient has no adverse reactions.
pt recvd vax 2NOV95 & 4NOV95 woke w/earache, & sore throat;evening of 4NOV95 throat very imflammed, cough, loss of voice which lasted 2 days; 14NOV95 persistant evening cough
10/26/2005 2 days ago child woke up with 5-6 bumps on her trunk. Now has 30 lesions. DX chicken pox over body  limbs and face. No fever Rx Benadryl PRN, DX Varicella.
13Sep90 pt vax;  21Sep90 noted bilateral cervical, axillary & inquinal lymphadenopathy accomp. by malaise & low-grade fever.  Seen by Md who saw no infection.  Lab tests normal.  08Oct90 cervical & axillary nodes were smaller.  See worm....
Patient has received this first monovalent pfizer vaccine and was supposed to receive their second dose to complete their initial series. However instead of receiving a monovalent vaccine they received a Bivalent dose.
Hospitalized 9/19/2021 COVID-19 positive 9/15/2021; fully vaccinated  Pt is a 26 y.o. female past medical history of POTS, episodic cluster headaches, anxiety, history of COVID infection who is presenting today with speech disturbance.  Patient had worsening health since originally diagnosed with COVID in November 2020. She states she was off work for 6 months.  She has been dealing with episodic cluster headaches.  She is currently weaning off Elavil, she had been trying triptans but had severe side effects.   Patient presented as stroke code to emergency department.  Original NIH of 1. Patient was tachycardic but all other vital signs stable. NIHSS was 1 for LLE ataxia. Patient was emergently taken for advanced imaging. CT head revealed no evidence of acute infarction or hemorrhage. Tpa was not given due to low suspicion of stroke and low NIHSS. CTP revealed no evidence of core infarct or penumbra. CTA head/neck revealed no evidence of LVO or high grade stenosis.  She was seen by Neurology who recommended treating for complex migraines.  She did exhibit some degree of anxiety on exam, which was acknowledged by patient.  It was unclear what the source of the patient's transient aphasia was however it may be related to complex migraine/anxiety/post COVID neurologic symptoms.  She was prescribed ketorolac/Compazine/lorazepam to be taken in limited duration after discharge.  She will follow-up with neurology.  She was discharged home on 09/20/2021 in stable condition. COVID-19  - original + test 11/2020; positive again 9/15/2021. Status post monoclonal antibody 9/16/2021.
Back of right leg 6" from knee is red, itchy and burns when touched.  By Sunday November 20th Back of right leg has painful clear vesicles.  November 21 in AM left leg has rash multiple vesicles.  Went to Physical Therapist who told patient it was "shingles".  November 24th bit by an insect subsequent wound became infected with "shingles". Sunday December 11th had an outbreak of HSV2 in the genital area.  Went to MD same day told by MD (no tests were done) it was genital herpes and placed on oral and topical medication (did not give name of med). Multiple vesicular rash did NOT resolve until February.
Pt was clothing shopping with mom and fiance. She was trying on clothes and c/o severe throbbing pain (L) elbow to wrist at 1 PM. Was given Advil and went home to ice arm.
Patient was administered vaccine at the pharmacy around 1pm and there was no reaction immediately. Patient called around 5:30 pm to report that their left arm(arm of vaccination) is swollen and feels hot around injection site. They did take ibuprofen and Benadryl but no change. Advised patient to contact PCP/911 or visit ER if condition worsens. No trouble breathing.
pt recvd vax;warm to touch;apap given;T 101.6;v light yellow;fever dec 99;pt trembling,tremors of arms,legs,middle of body;staring;no response,pale face;lt arm began red,swollen warm by 8pm;no tx, 25jan arm warm, red 3x3" raised area;apap;
Sore at injection site; Headache; Tiredness; General malaise; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via unspecified route of administration in left arm on 16Mar2021 at 03:00 PM (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included digestive allergy to milk and gluten. The patient had previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EL3247) via unspecified route of administration on the left arm on 23Feb2021 at 02:45 PM as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included Allegra and unspecified vitamins (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. On 17Mar2021 at 06:00 AM, the patient experienced sore at injection site, headache, tiredness and general malaise. The patient did not receive treatment for the reported events. The clinical outcome of the events sore at injection site, headache, tiredness and general malaise was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Felt extreme fatigue at 3:00 in the afternoon, then by 4:00 bad headache, chills with trembling, muscle and joint pain , general weakness, and "felt terrible".  Slept fitfully, first in recliner then bed, till 8:00 next morning.  By 9:00, felt fine.
dry mouth; feverish; fatigue; Flu also received on 02Oct2022; Flu also received on 02Oct2022; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the parent.  A 30-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5, on 02Oct2022 at 16:45 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 30 years for covid-19 immunisation; influenza vaccine (FLU [INFLUENZA VACCINE]), on 02Oct2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. No covid prior vaccination. No covid tested post vaccination. No other vaccine in four weeks. Vaccination history included: BNT162b2 (Dose 1, single, in arm left, at 12:00 PM), administration date: 17Mar2021, when the patient was 28-year-old, for COVID-19 immunization; BNT162b2 (Dose 2, single, in arm left, at 04:00 PM), administration date: 07Apr2021, when the patient was 28-year-old, for COVID-19 immunization; BNT162b2 (Dose 3 (booster), single, at 01:00), administration date: 02Dec2021, when the patient was 29-year-old, for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 02Oct2022, outcome "unknown" and all described as "Flu also received on 02Oct2022"; DRY MOUTH (non-serious) with onset 03Oct2022, outcome "recovered"; FATIGUE (non-serious) with onset 03Oct2022, outcome "recovered"; PYREXIA (non-serious) with onset 03Oct2022, outcome "recovered", described as "feverish". Therapeutic measures were not taken as a result of dry mouth, pyrexia, fatigue.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101720607 same patient, different dose/event;
CYST LIKE LUMP THAT APPEARED ON A TENDON; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow up on batch/lot number.  No concomitant medications were reported. On APR-2021, the subject experienced cyst like lump that appeared on a tendon. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of cyst like lump that appeared on a tendon was not reported. This report was non-serious.
Friday was the worst day in terms of size of the welt/hard spot, Sunday it was gone completely; Soreness in arm; Swelling about diameter of golf ball where shot was given; Headache; Tired; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Friday was the worst day in terms of size of the welt/hard spot, Sunday it was gone completely), PAIN IN EXTREMITY (Soreness in arm), INJECTION SITE SWELLING (Swelling about diameter of golf ball where shot was given), HEADACHE ( Headache) and FATIGUE (Tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Friday was the worst day in terms of size of the welt/hard spot, Sunday it was gone completely), PAIN IN EXTREMITY (Soreness in arm), INJECTION SITE SWELLING (Swelling about diameter of golf ball where shot was given), HEADACHE ( Headache) and FATIGUE (Tired). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Friday was the worst day in terms of size of the welt/hard spot, Sunday it was gone completely), PAIN IN EXTREMITY (Soreness in arm), INJECTION SITE SWELLING (Swelling about diameter of golf ball where shot was given), HEADACHE ( Headache) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment. No concomitant medications were reported.   Patient developed welt/hard spot that was bigger in size and it was gone on Sunday but again came back even larger than before and measured 2.5 inches in length and 1.5 inches in height and was warm to touch.
Received pain after injection; woke up with (L) ear, (L) neck pain, rash on top of left shoulder; sharp pains radiate to (L) ear; PCP evaluated & prescribed MEDROL dose pack for one week.
t102.4, h/a, head congestion,nausea, slept alot, drank plenty of fluids, also had chills;fever broke about 7PM & pt was fine next day;
Mom state pt c/o pain at site after immunization and refused to ambulate 10/22/05.  Diffuse rash to inner thigh 10/23 - 10/24 left inner thigh with swelling, redness, bruising - ambulating without c/o. Tx: Zyrtec 7.5mg, bud; Duricef 250mg bid times 7d
Information has been received from a physician concerning a 6 year old female who on an unspecified date was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (lot#656425/1182U). On an unspecified date after receiving the vaccine, she developed redness at the injection site. Medical attention sought, and current patient status was not reported. A product quality complaint was not reported. This is one of three reports from the same source. Additional information has been requested.
Pt developed 6 x 9 cm area of redness, swelling, warmth, tenderness around the vaccine site.  Rx'd with KEFLEX.
Patient received a full dose of Moderna covid vaccine instead of a booster dose of Moderna covid vaccine.  Patient is aware and reported no symptoms or concerns at the time.
Radiating arm pain after vaccination. last about 1 to 1& 1/2 weeks. Aching when lifting.
Felt Dizzy, to the point of passing out for 2 days following vaccine. No treatment sought.
Per Dr's note: 7x9cm erythema. No induration. No tenderness. Treatment: Ice/ Benadryl. Left thigh.
Moderna COVID-19 Vaccine EUA Swelling and tenderness at vax site on right arm; began 5 hours after administration, persisted until day 3 post-vax. General body aches (Skin/muscle/joints); began morning of following day after administration, persisted until day 2 post-vax. Strong headache; began evening of following day after administration, persisted until day 3 post-vax Low grade fever; began afternoon of following day after administration, duration only 3 hours. Fatigue; began morning of following day after administration, persisted until day 3 post-vax.
NECK PAIN; HEADACHE; NAUSEA; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 13-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 18-MAR-2021, the subject experienced neck pain. On 18-MAR-2021, the subject experienced headache. On 18-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, nausea, and neck pain. This report was non-serious.
Fever (100.4F), chills, and muscle ache started within 24 hours and lasted for one day. Took Tylenol which eliminate the fever and all the aforementioned issues were resolved.  The second day noticed swollen painful lymph nodes on the right side of my collarbone (same side of the injection). The issue is still ongoing. Currently, I am taking Ibuprofen and using warm compression to alleviate pain.
PATIENT ADMITTED ON 12/11 THRU ED REPORTING WEAKNESS X 2 DAYS. PATIENT HAD FLU VACCINE GIVEN IN NOVEMBER. (NOT AT OUR FACILITY) DEVELOPED WEAKNESS, BILATERAL MORE SO ON LOWER EXTREMITIES, DECREASED REFLEXES BILAT, HYPERTENSION, WEAKNESS PROGRESSING. PATIENT TRANSFERRED TO HIGHER LEVEL OF CARE: HOSPITAL ON 12/13.
COVID VACCINATIONS 1/6/21 MODERNA LOT # 032H20A GIVEN AT HEALTH DEPT SECOND DOSE NOTED ABOVE. PATIENT SEEN AT ER. TRANSFERRED TO MEDICAL CENTER FOR HIGHER LEVEL OF CAE. PATIENT NOTED TO HAVE FEVERS 101, PRODUCTIVE COUGH, SHORTNESS OF BREATH. REQUIRED 3L OF O2.PATIENT DID NOT USE HOME O2 PRIOR . NOW O2 UP TO 6 L. DX; PNA, ACUTE RENAL FAILURE, ATRIAL FEB, CAD, HYPERTENSION, HYPERLIIDEMIA, BPH.PATIENT TREATED ON STEP DOWN MEDICAL UNIT. DISCHARGED 8/18/21 TO HOME WITH HOME HEALTH NURSING AND THERAPY.
This spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved 06-Jun-2018 by Seqirus from VAERS (VAERS ID: 730224), concerns a 19-year-old, adult, female patient. The patient's historical vaccine included influenza vaccine in 2011 (at age 17) and in 2012 (at age 18), which caused severe muscle aches. On an unspecified date in 2013, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On an unspecified date, after vaccination, the patient experienced severe muscle aches, which lasted more than three days. At the time of this report, the outcome of the event was not reported. The reporter assessed the event as non-serious. This case 201802207 was cross linked to case 201802205 reported by same reporter.